KERALA AYURVEDA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 297 INR | +1.02% |
|
-2.04% | +11.36% |
| Jan. 04 | Kerala Ayurveda Limited announced that it has received INR 212.00963 million in funding | CI |
| 2023 | Kerala Ayurveda Limited announced a financing transaction | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 804M 9.65M | Sales 2023 | 936M 11.24M | Capitalization | 880M 10.57M |
|---|---|---|---|---|---|
| Net income 2022 | 23M 276K | Net income 2023 | -9M -108K | EV / Sales 2022 | 1.86 x |
| Net Debt 2022 | 671M 8.05M | Net Debt 2023 | 692M 8.32M | EV / Sales 2023 | 1.68 x |
| P/E ratio 2022 |
35.1
x | P/E ratio 2023 |
-97.7
x | Employees | 265 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.46% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.02% | ||
| 1 week | -2.04% | ||
| Current month | -5.23% | ||
| 1 month | -1.02% | ||
| 3 months | +2.75% | ||
| 6 months | +29.04% | ||
| Current year | +11.36% |
1 week
287.10
308.65
1 month
272.45346.60
Current year
249.95346.60
1 year
100.50346.60
3 years
52.00346.60
5 years
26.15346.60
10 years
25.00346.60
| Managers | Title | Age | Since |
|---|---|---|---|
Vivek Sunder
CEO | Chief Executive Officer | - | 23-10-02 |
| Director of Finance/CFO | - | 22-06-27 | |
.Jyothi Gulecha
CMP | Compliance Officer | - | 23-02-13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ramesh Vangal
FOU | Founder | 69 | 06-09-01 |
| Director/Board Member | 85 | 09-03-21 | |
| Director/Board Member | 69 | 06-06-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 297 | +1.02% | 5 855 |
| 24-05-18 | 294 | -0.39% | 1,294 |
| 24-05-17 | 295.2 | -2.27% | 5,183 |
| 24-05-16 | 302 | +2.13% | 6,283 |
| 24-05-15 | 295.8 | -2.47% | 6,442 |
Delayed Quote Bombay S.E., May 21, 2024 at 06:00 am EDT
More quotes
Kerala Ayurveda Limited is an India-based company. The Company is primarily focused in the area of manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs and maintaining herbarium of medicinal plants. The Company's product categories include diabetes, organic superfood, child/kids health, diabetes/heart health, gastro care, eye care, joint care, lifestyle products, massage oils, men's care, renal care, respiratory and allergy, skin and hair care, women care, general health/immunity, gulika/pills/tab, arishtam, thailam, kwath tablets, and ayurveda soaps. The Company's subsidiaries include Ayurvedagram Heritage Wellness Centre Pvt Ltd., Ayurvedic Academy Inc, Suveda Inc, Ayu Natural Medicine Clinic PS, CM S Katra Holdings LLC, and Nutraveda Pte Ltd.
Calendar
2024-05-27
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +11.36% | 42.48M | |
| -11.01% | 1.44B | |
| -54.15% | 77.07M |
- Stock Market
- Equities
- KERALAYUR6 Stock
